A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

BACKGROUND: Docetaxel plus cisplatin and 5-fluorouracil has become a new standard for treating advanced gastric cancer. However, high rates of severe neutropenia limit its application. Modification of the regimen could be the solution to get similar activity but less myelosuppression. METHODS: Patie...

Full description

Saved in:
Bibliographic Details
Main Authors: Li, C-P, Chen, J-S, Chen, L-T, Yen, C-J, Lee, K-D, Su, W-P, Lin, P-C, Lu, C-H, Tsai, H-J, Chao, Y
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2010
Subjects:
Clinical Study
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2990611/
https://ncbi.nlm.nih.gov/pubmed/20924378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605928
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items